Management of glucocorticoid-induced osteoporosis

Long-term glucocorticoid (GC) therapy is frequently indicated to treat autoimmune and chronic inflammatory diseases in daily clinical practice. Two of the most devastating untoward effects are bone loss and fractures. Doses as low as 2.5 mg of prednisone for more than 3 months can impair bone integr...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Aging clinical and experimental research 2021-04, Vol.33 (4), p.793-804
Hauptverfasser:	Messina, Osvaldo D., Vidal, Luis Fernando, Wilman, Maritza Vidal, Bultink, Irene E. M., Raterman, Hennie G., Lems, William
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Arthritis Bone Density Bone Density Conservation Agents - adverse effects Clinical medicine Disease Drug dosages Fractures Geriatrics/Gerontology Glucocorticoids - adverse effects Health risks Humans Medicine Medicine & Public Health Osteoporosis Osteoporosis - chemically induced Osteoporosis - drug therapy Osteoporotic Fractures - chemically induced Osteoporotic Fractures - prevention & control Pathogenesis Review Rheumatology Womens health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!